Home » Newsletters » BioWorld

BioWorld

June 22, 1993

View Archived Issues

HYGEIA GETS SBIR GRANT

IDEC GETS PATENT ALLOWANCE

MIT CONFERENCE FOCUSES ON TECHNOLOGY POLICY IN '90S

MOUSE ALTERED TO FACILITATE STUDY OF BONE RESORBTION

APPOINTMENTS AND ADVANCEMENTS

BECKMAN TO SELL SEPRACOR'S HDLC MEDIA

OPHIDIAN GETS SBIR TO DEVELOP ANTITOXINS

PDL DRUGS GETS ORPHAN DRUG STATUS

IGI AWARDED PATENT

FDA TO STANDARDIZE TERMINOLOGY FOR REVIEWS

GORE MEETS WITH INDUSTRY LEADERS

CYTOTHERAPEUTICS BEGINS TRIALS

CELLEX GETS $500,000 SBIR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...